article · International Journal of Medicine and Health Development
A bstract Background: The two main phenotypic types of preeclampsia/eclampsia (P/E) are early and late onset. The classification is necessary for prognostication of the disorder and better management. In Nigeria, information regarding the prevalence and pregnancy outcomes is still sparse. Objectives: To determine the prevalence of phenotypic patterns and pregnancy outcomes of P/E patients in Nigeria. Materials and Methods: A multi-centered cross-sectional design was adopted. One hundred and thirty-three P/E patients were recruited consecutively over a period of 5 months, and a semi-structured questionnaire was used for data collection. Outcomes measured included the prevalence of P/E and the phenotypes, maternal characteristics of the phenotypes, delivery rate, and feto-maternal outcomes. Results: The prevalence of P/E was 7.2% (133 out of 1831 deliveries); proportions of early versus late onset phenotypes were 45.9% and 54.1%, respectively. There was no significant difference in the mode of delivery and adverse maternal outcomes, mean booking weight, and special baby care intensive unit admission between the two ( P > 0.05): however, live birth rate, birth weight, and gestational age at delivery were significantly higher in late-onset compared with early-onset P/E ( P = 0.032, <0.001, and <0.001, respectively). Conclusion: The prevalence of P/E was high; late onset P/E was slightly more frequent than the early onset phenotype. Perinatal outcome was better for late onset compared to early onset P/E. Therefore, since early onset phenotype, though less common, is associated with poorer outcomes, there should be prioritization of resources once diagnosed for improved outcome.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/ijmh.ijmh_65_24
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.